Following the inclusion of [S2 Text](https://doi.org/10.1371/journal.pmed.1002794.s003) in the original article to disclose the role of the funder Illumina in this study, the financial disclosure was not updated to reflect the same information. The Funding should read:

REC, CMD, TCR, and AM had funding from the Department for International Development from the United Kingdom award (204074--101) and Department of Foreign Affairs and Trade Australian Government award (70957). TCR had funding from National Institute of Allergy and Infectious Diseases (grant number: R21AI135756). MS was supported from the National Heart, Lung, and Blood Institute at the National Institutes of Health (grant number: T32HL134632). Illumina supplied early-access iSeq100 sequencing reagents; some experiments were conducted at Illumina by Illumina employees; the role of the funder Illumina is further described in [S2 Text](https://doi.org/10.1371/journal.pmed.1002794.s003). The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
